Clinical TrialsSearch results
Number of results: 62436
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- X1 study
- Colon polyp
- Division of Endoscopy, Shizuoka Cancer Center
- 2022-07-31
Other
- WT1-antigen specific TCR-gene transduced T lymphocytes transfer using MS3-WT1-siTCR vector for acute myelogeneous leukemia and myelodysplastic syndrome
- acute myelogenous leukemia, myelodysplastic syndrome
- Mie University, Ehime University, Fujita Health University, Nagoya University, Takara Bio Inc.
- 2013-08-19
Recruiting
- WT1 Trio Peptide-vaccine for Rare Cancers
- Thymic cancer Thymoma Soft tissue sarcoma Malignant glioma Salivary gland cancer Head and neck mucoepidermoid carcinoma Olfactory neuroblastoma Head and neck mucosal malignant melanoma Ophthalmic malignant melanoma Cancer of the external auditory canal Testicular cancer Cancer of penis Adrenal cancer Malignant mesothelioma Cancer of the small intestine Merkel cell carcinoma Cutaneous lymphoma (Rare cancers listed above)
- Osaka University Graduate School of Medicine Dept. Cancer Immunotherapy
- 2016-09-10
Recruiting
- WT1 peptide-pulsed dendritic cell therapy for wet age-related macular degeneration
- wet age-related macular degeneration
- Gunji Hisato
- 2021-05-07
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreatic and biliary tract cancers
- advanced pancreatic and biliary tract cancers
- Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine
- 2010-08-21
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer
- pancreas cancer
- Department of Cancer immunotherapy, Osaka University Medical School
- 2008-06-20
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer
- pancreas cancer
- Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine
- 2008-06-26
Not yet recruiting
- WT1 peptide-based cancer vaccine in patients with high risk rhabdomyosarcoma, a multicenter, phase 2 clinical study
- rhabdomyosarcoma
- Osaka university graduate school of medicine Pediatrics
- 2014-03-04
Recruiting
- WT1 peptide-based cancer vaccine for long-term maintenance of anti-tumor immunity
- solid tumor, malignant lymphoma, acute leukemia
- Osaka University Graduate Shool of Medicine, Functional Diagnostic Science
- 2014-12-20
Other
- WT1 peptide-based cancer vaccine combined with gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a randomised, multicenter, phase 2 clinical study
- Pancreatic cancer
- Department of Cancer Immunotherapy, Osaka university Graduate school of Medicine
- 2011-04-01